Abstract | BACKGROUND: OBJECTIVES: To investigate whether dasatinib affects skin wound healing. METHODS: A single (4-mm diameter) full-thickness excisional skin wound was generated in mice. Dasatinib (5 or 10 mg/kg) or dimethyl sulfoxide ( DMSO) vehicle was intraperitoneally injected daily during the first 4 days. The wound was monitored over 9 days post injury. RESULTS:
Dasatinib induced loss of vascular integrity during the inflammatory phase of wound repair (day 1 to day 3 post injury), which was associated with the inhibition of platelet function stimulated by collagen and rhodocytin, the ligands for GPVI and CLEC-2, respectively. Dasatinib-treated mice, particularly at 5 mg/kg, exhibited accelerated wound closure compared to DMSO-treated controls. Transient bleeding into the wound during the inflammatory phase in dasatinib-treated mice allowed for extravasation of fibrinogen. The increased deposition of fibrinogen and fibrin in the wound on day 3 post injury was associated with the augmented progression of re-epithelialization and angiogenesis, attenuated infiltration of neutrophils and macrophages, and decreased levels of tumor necrosis factor-α (TNF-α). CONCLUSIONS: Our data show that dasatinib promotes skin wound healing, and the mechanisms include blocking GPVI- and CLEC-2-mediated platelet activation, leading to self-limited inflammatory bleeding and fibrinogen/ fibrin deposition, in association with reduced inflammation, increased re-epithelialization, and enhanced angiogenesis.
|
Authors | Surasak Wichaiyo, Saovaros Svasti, Wasu Supharattanasitthi, Noppawan Phumala Morales |
Journal | Journal of thrombosis and haemostasis : JTH
(J Thromb Haemost)
Vol. 19
Issue 12
Pg. 3154-3167
(12 2021)
ISSN: 1538-7836 [Electronic] England |
PMID | 34402195
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2021 International Society on Thrombosis and Haemostasis. |
Chemical References |
- Lectins, C-Type
- Platelet Membrane Glycoproteins
- Protein-Tyrosine Kinases
- Dasatinib
|
Topics |
- Animals
- Blood Platelets
- Dasatinib
(therapeutic use)
- Lectins, C-Type
- Mice
- Platelet Activation
- Platelet Membrane Glycoproteins
- Protein-Tyrosine Kinases
- Skin
- Wound Healing
(drug effects)
|